COMPARISON OF MORPHONUCLEAR FEATURES IN NORMAL, BENIGN AND NEOPLASTIC THYROID-TISSUE BY DIGITAL CELL IMAGE-ANALYSIS

被引:0
|
作者
SALMON, I
KISS, R
FRANC, B
GASPERIN, P
HEIMANN, R
PASTEELS, JL
VERHEST, A
机构
[1] UNIV LIBRE BRUXELLES,FAC MED,HISTOL LAB,808 ROUTE LENNIK,B-1070 BRUSSELS,BELGIUM
[2] ERASMUS UNIV,DEPT PATHOL & CYTOGENET,3000 DR ROTTERDAM,NETHERLANDS
[3] FREE UNIV BRUSSELS,FAC MED,HISTOL LAB,B-1050 BRUSSELS,BELGIUM
[4] JULES BORDET INST,DEPT RADIOTHERAPY,BRUSSELS,BELGIUM
[5] ST PIERRE HOSP,DEPT PATHOL,BRUSSELS,BELGIUM
[6] AMBROISE PARE HOSP,DEPT PATHOL,BOULOGNE,FRANCE
[7] EVANGEL FAC MED,DEPT GYNECOL,CURITIBA,PARANA,BRAZIL
来源
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY | 1992年 / 14卷 / 01期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We analyzed the morphonuclear features of thyroid cell nuclei from 10 normal tissues (10 multinodular goiters), 10 benign tissues (10 adenomas) and 10 neoplastic tissues (10 carcinomas - 2 follicular, 2 medullary and 6 papillary). These morphonuclear features quantitatively described the nuclear size, DNA content and chromatin texture of 200-400 Feulgen-stained cell nuclei that were digitized by means of a cell image processor. Nuclear DNA estimations revealed that the benign thyroid tumors showed an aneuploidy level that was not different from that of the neoplastic tissues. Morphometric measurements showed a significant and positive correlation between an increase in nuclear area and the development of thyroid pathology-i.e., from normal to a neoplastic stage. We also observed a significant decrease in chromatin condensation and heterogeneity from normal to neoplastic thyroid tissue. In the specific case of thyroid tumors, such criteria were not found sufficient per se for a diagnosis of malignancy. More detailed data banks will be necessary for this purpose.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [1] FACTORS INFLUENCING THE GROWTH OF NORMAL AND NEOPLASTIC THYROID-TISSUE
    DUH, QY
    CLARK, OH
    SURGICAL CLINICS OF NORTH AMERICA, 1987, 67 (02) : 281 - 298
  • [2] THYROTROPIN RECEPTORS IN NORMAL AND NEOPLASTIC HUMAN THYROID-TISSUE
    CLARK, OH
    CASTNER, BJ
    SURGERY, 1979, 85 (06) : 624 - 632
  • [3] ESTROGEN AND THYROID STIMULATING HORMONE RECEPTORS IN NORMAL AND NEOPLASTIC THYROID-TISSUE
    CLARK, OH
    GEREND, PL
    DAVIS, M
    GORETZKI, P
    NISSENSON, RA
    HOFFMAN, P
    CLINICAL RESEARCH, 1983, 31 (01): : A83 - A83
  • [4] ESTROGEN-RECEPTOR IN NORMAL AND NEOPLASTIC HUMAN THYROID-TISSUE
    CHAUDHURI, PK
    PRINZ, R
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1989, 10 (05) : 322 - 326
  • [5] EPIDERMAL GROWTH-FACTOR RECEPTORS IN NORMAL AND NEOPLASTIC THYROID-TISSUE
    DUH, QY
    GUM, ET
    GEREND, PL
    RAPER, SE
    CLARK, OH
    SURGERY, 1985, 98 (06) : 1000 - 1007
  • [6] GUANYL NUCLEOTIDE REGULATORY PROTEINS IN NEOPLASTIC AND NORMAL HUMAN THYROID-TISSUE
    CLARK, OH
    GUM, ET
    SIPERSTEIN, AE
    GEREND, PL
    WORLD JOURNAL OF SURGERY, 1988, 12 (04) : 538 - 545
  • [7] MORPHONUCLEAR RELATIONSHIP BETWEEN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND CANCERS AS ASSESSED BY DIGITAL CELL IMAGE-ANALYSIS
    PETEIN, M
    MICHEL, P
    VANVELTHOVEN, R
    PASTEELS, JL
    BRAWER, MK
    DAVIS, JR
    NAGLE, RB
    KISS, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (05) : 628 - 634
  • [8] THYROTROPIN RECEPTORS IN NORMAL AND NEOPLASTIC (PRIMARY AND METASTATIC) CANINE THYROID-TISSUE
    VERSCHUEREN, CP
    RUTTEMAN, GR
    VOS, JH
    VANDIJK, JE
    DEBRUIN, TWA
    JOURNAL OF ENDOCRINOLOGY, 1992, 132 (03) : 461 - 468
  • [9] THE USE OF DIGITAL CELL IMAGE-ANALYSIS OF FEULGEN-STAINED NUCLEI TO QUANTITATIVELY DESCRIBE MORPHONUCLEAR FEATURES IN A SERIES OF 174 MENINGIOMAS
    SALMON, I
    CAMBY, I
    GRAS, T
    ROMBAUT, K
    PASTEELS, JL
    KISS, R
    MODERN PATHOLOGY, 1994, 7 (05) : 570 - 577
  • [10] IN-VITRO DIGITAL CELL IMAGE-ANALYSIS OF MORPHONUCLEAR MODIFICATIONS INDUCED BY NATURAL DNA-INTERACTING ANTICANCER DRUGS IN 3 NEOPLASTIC CELL-LINES
    PAUWELS, O
    PASTEELS, JL
    ATASSI, G
    KISS, R
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1995, 17 (03): : 151 - 162